World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
60
Citations
17870
World Ranking
3291
National Ranking
1531

Sergio D. Rosenzweig publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Sergio D. Rosenzweig sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 232 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Sergio D. Rosenzweig D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Sergio D. Rosenzweig sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 60 D-Index — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Sergio D. Rosenzweig is affiliated with the National Institutes of Health in the United States. Their research spans across multiple areas in medicine, immunology, and molecular biology, with a particular focus on immunodeficiency and autoimmune disorders.

Their main fields of study include Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Subfields of their work cover Immunology, Molecular Biology, Genetics, Epidemiology, and Infectious Diseases.

Key topics addressed in their research encompass Immunodeficiency and Autoimmune Disorders, Immune Cell Function and Interaction, Acute Lymphoblastic Leukemia research, T-cell and B-cell Immunology, NF-κB Signaling Pathways, Blood disorders and treatments, and Genetics and Neurodevelopmental Disorders.

Frequent co-authors collaborating with them are:

  • Hye Sun Kuehn
  • Julie E. Niemela
  • Jennifer Stoddard
  • Luigi D. Notarangelo
  • Thomas A. Fleisher

They have published extensively in several scientific venues, with a notable number of contributions to the following journals:

  • Journal of Clinical Immunology
  • Clinical Immunology
  • Journal of Allergy and Clinical Immunology
  • Blood
  • Frontiers in Immunology

Among their recent papers are:

  • Targeted therapy guided by single-cell transcriptomic analysis in drug-induced hypersensitivity syndrome: a case report, 2020, Nature Medicine
  • The expansion of human T-bet high CD21 low B cells is T cell dependent, 2021, Science Immunology
  • Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease, 2023, The Journal of Experimental Medicine
  • Primary Immunodeficiency Diseases and Bacillus Calmette-Guérin (BCG)-Vaccine-Derived Complications: A Systematic Review, 2020, The Journal of Allergy and Clinical Immunology In Practice
  • Systemic Type I IFN Inflammation in Human ISG15 Deficiency Leads to Necrotizing Skin Lesions, 2020, Cell Reports

Best Publications

  • Activated STING in a Vascular and Pulmonary Syndrome

    Y. Liu;A.A. Jesus;B. Marrero;D. Yang

  • De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.

    Ivona Aksentijevich;Miroslawa Nowak;Mustapha Mallah;Jae Jin Chae

  • Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2

    Qing Zhou;Dan Yang;Amanda K Ombrello;Andrey V Zavialov

  • Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation.

    Stéphanie Dupuis;Catherine Dargemont;Claire Fieschi;Nicolas Thomassin

  • Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources

    Sebastian Köhler;Leigh Carmody;Nicole A. Vasilevsky;Julius O. B. Jacobsen

  • Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype.

    Julie Toubiana;Satoshi Okada;Satoshi Okada;Julia Hiller;Matias Oleastro

  • Gastrointestinal involvement in chronic granulomatous disease.

    Beatriz E Marciano;Sergio D Rosenzweig;David E Kleiner;Victoria L Anderson

  • Clinical features of dominant and recessive interferon γ receptor 1 deficiencies

    Susan E. Dorman;Capucine Picard;Capucine Picard;David Lammas;Klaus Heyne

  • Revisiting Human IL-12Rβ1 Deficiency: A Survey of 141 Patients From 30 Countries

    Ludovic de Beaucoudrey;Arina Samarina;Arina Samarina;Arina Samarina;Jacinta Bustamante;Jacinta Bustamante;Aurélie Cobat;Aurélie Cobat

  • Common Severe Infections in Chronic Granulomatous Disease

    Beatriz E. Marciano;Christine Spalding;Alan Fitzgerald;Daphne Mann

  • NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells

    Adriana R. Mantegazza;Ariel Savina;Mónica Vermeulen;Laura Pérez

  • Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome

    Alexandra Y. Kreins;Alexandra Y. Kreins;Michael J. Ciancanelli;Satoshi Okada;Xiao Fei Kong

  • Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease

    Najoua Lalaoui;Najoua Lalaoui;Steven E. Boyden;Hirotsugu Oda;Geryl M. Wood

  • Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy

    Elise M.N. Ferre;Stacey R. Rose;Sergio D. Rosenzweig;Peter D. Burbelo

  • Defects in the interferon-gamma and interleukin-12 pathways.

    Sergio D. Rosenzweig;Steven M. Holland

  • BCG vaccination in patients with severe combined immunodeficiency: Complications, risks, and vaccination policies

    Beatriz E. Marciano;Chiung Yu Huang;Gyan Joshi;Nima Rezaei

  • Effective “activated PI3Kδ syndrome”–targeted therapy with the PI3Kδ inhibitor leniolisib

    V. Koneti Rao;Sharon Webster;Virgil A. S. H. Dalm;Anna Šedivá

  • Loss of B Cells in Patients with Heterozygous Mutations in IKAROS

    Hye Sun Kuehn;Bertrand Boisson;Charlotte Cunningham-Rundles;Janine Reichenbach

  • Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease

    Qing Zhou;Xiaomin Yu;Erkan Demirkaya;Natalie Deuitch

  • Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis

    Elizabeth P. Sampaio;Elizabeth P. Sampaio;Amy P. Hsu;Joseph Pechacek;Hannelore I. Bax;Hannelore I. Bax

  • Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations

    Guillaume Vogt;Ariane Chapgier;Kun Yang;Kun Yang;Nadia Chuzhanova

Frequent Co-Authors

Steven M. Holland
Steven M. Holland National Institute of Allergy and Infectious Diseases
Thomas A. Fleisher
Thomas A. Fleisher National Institutes of Health
Gulbu Uzel
Gulbu Uzel National Institute of Allergy and Infectious Diseases
Jean-Laurent Casanova
Jean-Laurent Casanova The University of Texas Southwestern Medical Center
Luigi D. Notarangelo
Luigi D. Notarangelo National Institutes of Health
Joshua D. Milner
Joshua D. Milner Columbia University
Alexandra F. Freeman
Alexandra F. Freeman National Institute of Allergy and Infectious Diseases
Steven M. Holland
Steven M. Holland University of Georgia
Andrea Bernasconi
Andrea Bernasconi Montreal Neurological Institute and Hospital
Bertrand Boisson
Bertrand Boisson Rockefeller University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Nursing programs, for example, provide a strong foundation in patient care and clinical skills, often complementing immunology knowledge. Many students seek the best easiest lpn programs to get into as an accessible entry point into the nursing field.

Advancing further, nurse practitioner degrees integrate advanced clinical training with specialized knowledge. Prospective students may find the easiest nurse practitioner degree programs appealing due to their flexibility and streamlined pathways.

For those interested in mental health alongside immunology, becoming a Psychiatric-Mental Health Nurse Practitioner (PMHNP) offers a unique crossover. High-quality options such as the top online pmhnp programs with best clinical placement rates provide strong support in clinical training and hands-on experience.

Affordability is also key when selecting programs. The cheapest pmhnp certificate programs allow students to pursue advanced qualifications without excessive financial burden, broadening access to this rewarding career path.

Best Scientists Citing Sergio D. Rosenzweig

Trending Scientists

Recently Published Articles